LAPS score for individualized treatment of advanced EGFR-mutated non-small cell lung cancer receiving EGFR-TKIs with or without bevacizumab.

Annals of medicine（2023）

引用 0|浏览7

暂无评分

摘要

Novel LAPS score may help to facilitate individualized treatment of advanced EGFR-mutated NSCLC receiving EGFR-TKI with or without bevacizumab.

查看译文

关键词

Non-small cell lung cancer,EGFR mutation,LAPS score,Risk stratification,Individualized treatment

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要